Browsing: Phibion Makuwerere

Blue Label’s share price has been on a strong run since it announced its intention to invest a 35% equity stake in Cell C at the end of last year. Coupled with good growth numbers in its first half 2016 results, it has gained more than 60% so far

Reunert has weathered excess capacity and produced commendable bottom-line growth, while still holding onto the cash from the disposal of Nashua Mobile’s subscriber bases, which is earning